- Condition: Factory New
- Weight: 0.63 lb
-
Learn more:
- MFR: CorDx Inc Ships from MFI Medical
- MPN: ACT21002110
Frequently asked questions
Does this test detect multiple viruses at once?
Yes, this is a multiplex test that allows you to simultaneously detect and differentiate between:
- SARS-CoV-2 (COVID-19)
- Influenza A
- Influenza B
How quickly can I expect to see the results?
The CorDx Tyfast test is designed for efficiency, providing clear, visual diagnostic results in just 10 minutes.
Is this test easy enough for home use?
Absolutely. It is specifically engineered for effortless self-administration. It is suitable for individuals aged 14 and older, and can be used for children aged 2 and older with the assistance of an adult.
What is the recommended testing frequency for accuracy?
To ensure the highest level of accuracy, the test protocol requires users to test at least twice over a three-day period, with a minimum of 48 hours between each test.
Is this a high-quality test with official authorization?
Yes, this test is manufactured in the United States and has received FDA Emergency Use Authorization (EUA), ensuring it meets professional standards for at-home diagnostic tools.
What kind of sample is required for the test?
This test utilizes a simple and non-invasive anterior nasal swab sample, making the collection process straightforward and comfortable.
Is the kit fully equipped with everything I need?
Each kit is comprehensive and includes:
- 1 Test Cassette
- 1 Swab
- 1 Tube with Sample Processing Solution
- 1 Quick Reference Instruction guide
Is there a specific timeframe during which I should use this?
The test is intended for use within the first five days of symptom onset to help you make informed decisions about your health early in the course of an illness.
Are the components compliant with quality standards?
Yes, the product is both Buy American Act (BAA) compliant and Trade Agreement Act (TAA) compliant, reflecting high manufacturing standards.
Should I rely solely on a negative test result?
Negative results are considered presumptive. They should not be used as the sole basis for treatment or isolation decisions, as they do not rule out the potential for infection or co-infection with other pathogens.